25.10.2012
- Biogen reported much higher-than-expected third-quarter profit on Thursday on increased sales of its drugs for multiple sclerosis and cancer, and the U.S. biotechnology company...
25.10.2012
- Celgene's quarterly earnings rose 14%, beating expectations, on strong sales of its Revlimid cancer treatment and lower costs, and the biotechnology company narrowly raised its...
25.10.2012
- French drugmaker Sanofi forecast 2012 earnings would fall less than expected as cost cuts and demand for diabetes and rare disease drugs cushion the blow from patent expiries...
25.10.2012
- Belgian chemicals and plastics maker Solvay reported a larger-than-expected core profit on Thursday, with record results from its consumer chemicals and speciality plastics. The...
25.10.2012
- Dow Chemical Chief Executive Andrew Liveris defended on Wednesday his decision to slash spending on capital projects, saying the cuts will not deter the chemical maker from meeting...
25.10.2012
- AstraZeneca's sales slumped 19% in the third quarter, underscoring the scale of the challenge confronting the drugmaker's new chief executive, Pascal Soriot. Faced with patent...
24.10.2012
- Thailand's Siam Cement doubled its forecast for sales growth of the construction material this year, but maintained its forecast for a fall in overall earnings as weak...
24.10.2012
- Amgen on Tuesday reported higher-than-expected third-quarter profit in its first full quarter under Chief Executive Robert Bradway and it raised its full-year earnings and revenue...
